US5861023A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes
Assignee: Pacesetter Inc
•
Filing: 1997-12-16
•
Granted: 1999-01-19
•
Expires: 2017-12-16
Abstract
Abstract An implantable lead includes a distal portion carrying a tissue-stimulating electrode having an outer surface and an inner surface, at least a portion of the outer surface of the electrode being adapted to stimulate cardiac tissue. At least one of the surfaces of the stimulating electrode includes an overlay of a sulfonated thermoplastic elastomer/rubber for minimizing adhesion and tissue ingrowth while passing sufficient electrical current to stimulate the tissue. The overlay may comprise a coating, film, tube, sleeve or other encapsulation. Sulfonated block copolymers of styrene-ethylene-butylene-styrene (SEBS), styrene-ethylene-propylene-styrene (SEPS), styrene-isoprene-styrene and styrene-isobutylene-styrene are effective to inhibit the formation of thrombus at the shocking electrode. In addition, when these copolymers absorb body fluids, they swell and infiltrate the interstices of the electrode coils thereby inhibiting tissue ingrowth. Furthermore, such materials, while non-porous, are conductive and thus do not impede the flow of electrical current at sulfonation levels above at least about 30%, with the optimal level residing between about 40% and about 70%. Although the above-described sulfonated block copolymers are preferred, other hydrogel-like materials may be employed including p-HEMA (polyhydroxymethacrylate), PEG (polyethylene glycol) acrylates, and cross-linked PVP (polyvinylpyrrolidone), and polyurethane hydrogels.
Inventors
- 👤 David J. Vachon
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 19:22
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/0563
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
64 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which is adapted to stimulate cardiac tissue, and an inner surface, at least one of the surfaces of the stimulating electrode including an overlay of a sulfonated thermoplastic elastomer/rubber for minimizing adhesion and tissue ingrowth while passing sufficient electrical current to stimulate the tissue.
Claim 2
Dependent Claim
64 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which is adapted to stimulate cardiac tissue, and an inner surface, at least one of the surfaces of the stimulating electrode including an overlay of a sulfonated thermoplastic elastomer/rubber for minimizing adhesion and tissue ingrowth while passing sufficient electrical current to stimulate the tissue.
Claim 3
Dependent Claim
23 words
An implantable lead, as defined in claim 1, in which the sulfonated thermoplastic elastomer/rubber has a sulfonation level of at least about 30%.
Claim 4
Dependent Claim
24 words
An implantable lead, as defined in claim 2, in which the sulfonated thermoplastic elastomer/rubber has a sulfonation level between about 40% and about 70%.
Claim 5
Dependent Claim
16 words
An implantable lead, as defined in claim 1, in which the sulfonated thermoplastic elastomer/rubber comprises styrene-ethylene-butylene-styrene.
Claim 6
Dependent Claim
16 words
An implantable lead, as defined in claim 1, in which the sulfonated thermoplastic elastomer/rubber comprises styrene-butadiene.
Claim 7
Dependent Claim
16 words
An implantable lead, as defined in claim 1, in which the sulfonated thermoplastic elastomer/rubber comprises styrene-isoprene-styrene.
Claim 8
Dependent Claim
16 words
An implantable lead, as defined in claim 1, in which the sulfonated thermoplastic elastomer/rubber comprises styrene-isobutylene-styrene.
Claim 9
Dependent Claim
71 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which adapted to stimulate cardiac tissue, and an inner surface, at least one of said surfaces including an overlay of a hydrogel-like, sulfonated thermoplastic elastomer/rubber selected from the group consisting of styrene-ethylene-butylene-styrene, styrene-butadiene, styrene-isoprene-styrene and styrene-isobutylene-styrene, for minimizing adhesion and tissue ingrowth while passing sufficient electrical current to stimulate the tissue.
Claim 10
Dependent Claim
71 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which adapted to stimulate cardiac tissue, and an inner surface, at least one of said surfaces including an overlay of a hydrogel-like, sulfonated thermoplastic elastomer/rubber selected from the group consisting of styrene-ethylene-butylene-styrene, styrene-butadiene, styrene-isoprene-styrene and styrene-isobutylene-styrene, for minimizing adhesion and tissue ingrowth while passing sufficient electrical current to stimulate the tissue.
Claim 11
Dependent Claim
19 words
An implantable lead, as defined in claim 8, in which the stimulating electrode is a defibrillation shocking coil electrode.
Claim 12
Dependent Claim
29 words
An implantable lead, as defined in claim 9, in which the hydrogel-like material is in the form of a coating or sleeve encapsulating the outer surface of the electrode.
Claim 13
Dependent Claim
30 words
An implantable lead, as defined in claim 9, in which the hydrogel-like material is in the form of a tube disposed in contact with the inner surface of the electrode.
Claim 14
Dependent Claim
29 words
An implantable lead, as defined in claim 9, in which the hydrogel-like material is impregnated in a tubular substrate disposed in contact with the inner surface of the electrode.
Claim 15
Dependent Claim
83 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which adapted to stimulate cardiac tissue, and an inner surface, at least one of said surfaces including an overlay of a hydrogel-like material selected from the group consisting of p-HEMA (polyhydroxymethacrylate), PEG (polyethylene glycol) acrylates, and cross-linked PVP (polyvinylpyrrolidone), and PVA (polyvinyl alcohol), and polyacrylamide and polyurethane hydrogels for minimizing adhesion and tissue ingrowth while providing sufficient electrical current to stimulate the tissue.
Claim 16
Dependent Claim
83 words
An implantable lead having a distal portion including a stimulating electrode having an outer surface at least a portion of which adapted to stimulate cardiac tissue, and an inner surface, at least one of said surfaces including an overlay of a hydrogel-like material selected from the group consisting of p-HEMA (polyhydroxymethacrylate), PEG (polyethylene glycol) acrylates, and cross-linked PVP (polyvinylpyrrolidone), and PVA (polyvinyl alcohol), and polyacrylamide and polyurethane hydrogels for minimizing adhesion and tissue ingrowth while providing sufficient electrical current to stimulate the tissue.
Claim 17
Dependent Claim
19 words
An implantable lead, as defined in claim 13, in which the stimulating electrode is a defibrillation shocking coil electrode.
Claim 18
Dependent Claim
29 words
An implantable lead, as defined in claim 14, in which the hydrogel-like material is in the form of a coating or sleeve encapsulating the outer surface of the electrode.
Claim 19
Dependent Claim
30 words
An implantable lead, as defined in claim 14, in which the hydrogel-like material is in the form of a tube disposed in contact with the inner surface of the electrode.
Claim 20
Dependent Claim
29 words
An implantable lead, as defined in claim 14, in which the hydrogel-like material is impregnated in a tubular substrate disposed in contact with the inner surface of the electrode.
References Cited (Backward Citations)
DE2604165A1
Cited
US4198991A
Cited
US4327747A
Cited
US4573480A
Cited
US4883070A
Cited
US4945922A
Cited
US5090422A
Cited
US5238007A
Cited
US5466252A
Cited
WO1994017852A1
Cited
US5431681A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-01-18 | 2002-07-20 | 2003-01-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-01-18 | 2006-07-20 | 2007-01-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-01-18 | 2010-07-20 | 2011-01-19 | $7700.00 | Window Closed / Lapsed |